• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单次应用抗风湿药金诺芬后人体中金的全身消除途径。

Whole body elimination routes of gold in humans after a single-dose application of the antirheumatic auranofin.

作者信息

Schnier C, Benn H P

机构信息

Institute of Physics, GKSS Research Centre, Geesthacht, FRG.

出版信息

Biol Trace Elem Res. 1990 Jul-Dec;26-27:471-7. doi: 10.1007/BF02992702.

DOI:10.1007/BF02992702
PMID:1704752
Abstract

After removal of the gallbladder (cholecystectomy) 7 patients were administered the antirheumatic agent Auranofin in its commercially available tablet form (Ridaura) 3 d postoperative. The single dose consisted of 5 tablets (4.35 mg of gold). Gold was determined in samples of blood, plasma, urine, bile, and feces (1-2 mL and 2.5 g, respectively). The specimens were drawn 10 min to 8 d p.a. and on d 14 p.a. The determinations were performed by instrumental neutron activation analysis (INAA). The limit of detection was less than 1 ng of gold. The courses of the mean gold concentrations show maxima after 1.9 h in blood and plasma, and after 16 h in urine and bile. The mean half-lives (terminal phases) are 7.6 d (blood), 23 d (plasma), and 6.5 d (bile).

摘要

在切除胆囊(胆囊切除术)后,7例患者在术后第3天服用了市售片剂形式的抗风湿药金诺芬(瑞得)。单次剂量为5片(4.35毫克金)。在血液、血浆、尿液、胆汁和粪便样本中测定金含量(分别为1 - 2毫升和2.5克)。在术后10分钟至8天以及术后第14天采集样本。通过仪器中子活化分析(INAA)进行测定。检测限低于1纳克金。平均金浓度曲线显示,血液和血浆中的金浓度在1.9小时后达到最大值,尿液和胆汁中的金浓度在16小时后达到最大值。平均半衰期(终末相)分别为血液7.6天、血浆23天和胆汁6.5天。

相似文献

1
Whole body elimination routes of gold in humans after a single-dose application of the antirheumatic auranofin.单次应用抗风湿药金诺芬后人体中金的全身消除途径。
Biol Trace Elem Res. 1990 Jul-Dec;26-27:471-7. doi: 10.1007/BF02992702.
2
[Biliary, renal and fecal elimination and distribution of gold after a single oral administration of auranofin, quantified by the instrumental neutron activation analysis method].[通过仪器中子活化分析法对单剂量口服金诺芬后金在胆汁、肾脏及粪便中的排泄与分布进行定量分析]
Z Rheumatol. 1991 Jan-Feb;50(1):32-8.
3
Pharmacokinetics of auranofin a single dose study in man.金诺芬的药代动力学:人体单剂量研究
J Rheumatol. 1990 Apr;17(4):466-8.
4
Phase I Clinical Trial Results of Auranofin, a Novel Antiparasitic Agent.新型抗寄生虫药金诺芬的I期临床试验结果
Antimicrob Agents Chemother. 2016 Dec 27;61(1). doi: 10.1128/AAC.01947-16. Print 2017 Jan.
5
Pharmacokinetics of auranofin in animals.
J Rheumatol Suppl. 1982 Jul-Aug;8:90-8.
6
Single dose pharmacokinetics of auranofin in rheumatoid arthritis.金诺芬在类风湿性关节炎中的单剂量药代动力学
J Rheumatol Suppl. 1982 Jul-Aug;8:110-9.
7
Auranofin versus injectable gold. Comparison of pharmacokinetic properties.
Am J Med. 1983 Dec 30;75(6A):114-22. doi: 10.1016/0002-9343(83)90483-7.
8
Gold excretion and retention during auranofin treatment: a preliminary report.
J Rheumatol Suppl. 1979;5:61-7.
9
Pharmacokinetics of gold sodium thiomalate.硫代苹果酸金钠的药代动力学
Res Commun Chem Pathol Pharmacol. 1982 Jul;37(1):33-47.
10
Clinical pharmacokinetics of oral and injectable gold compounds.口服和注射用金化合物的临床药代动力学
Clin Pharmacokinet. 1986 Mar-Apr;11(2):133-43. doi: 10.2165/00003088-198611020-00003.

引用本文的文献

1
Susceptibility of human head and neck cancer cells to combined inhibition of glutathione and thioredoxin metabolism.人头颈癌细胞对谷胱甘肽和硫氧还蛋白代谢联合抑制的敏感性。
PLoS One. 2012;7(10):e48175. doi: 10.1371/journal.pone.0048175. Epub 2012 Oct 31.

本文引用的文献

1
Mechanisms of bile secretion.胆汁分泌的机制。
J Am Med Assoc. 1959 Mar 28;169(13):1462-6. doi: 10.1001/jama.1959.03000300058011.
2
Pharmacokinetics of gold sodium thiomalate.硫代苹果酸金钠的药代动力学
Res Commun Chem Pathol Pharmacol. 1982 Jul;37(1):33-47.
3
An analysis of worldwide safety experience with auranofin.金诺芬的全球安全性经验分析。
J Rheumatol. 1985 Aug;12(4):695-9.